LUPIN
Back to Income Statement
|
LUPIN Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹20,011 Cr | ₹16,642 Cr | ₹16,405 Cr | ₹15,163 Cr | ₹15,375 Cr |
What is the latest Revenue of LUPIN ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹20,011 Cr |
| Mar2024 | ₹16,642 Cr |
| Mar2023 | ₹16,405 Cr |
| Mar2022 | ₹15,163 Cr |
| Mar2021 | ₹15,375 Cr |
How is Revenue of LUPIN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹20,011 Cr | 20.25 | |
| Mar2024 | ₹16,642 Cr | 1.44 | |
| Mar2023 | ₹16,405 Cr | 8.19 | |
| Mar2022 | ₹15,163 Cr | -1.38 | |
| Mar2021 | ₹15,375 Cr | - | |
Compare Revenue of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹105,187.7 Cr | -0.4% | 3.8% | 20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -0.4% |
3.8% |
20.1% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses